Amy Dan

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Ionis Pharmaceuticals (United States)25.2%
• University of Massachusetts Chan Medical School13.3%
• Alnylam Pharmaceuticals (United States)9.1%
• AstraZeneca (Sweden)7.2%
• Inserm6.1%
• Roche (Denmark)5.1%
• Other34.1%

Fields

• Biochemistry, Genetics and Molecular Biology45.4%
• Medicine21.2%
• Social Sciences17.2%
• Environmental Science5.5%
• Neuroscience3.7%
• Business, Management and Accounting1.1%
• Other5.9%

Topics

• RNA Interference and Gene Delivery18.5%
• Advanced biosensing and bioanalysis techniques15.8%
• DNA and Nucleic Acid Chemistry10.7%
• Climate Change Communication and Perception8%
• Environmental Education and Sustainability7.4%
• RNA Research and Splicing6%
• Other33.5%